Transplantation · 2021 · 13 citations · 31 references
MedicineSurgeryHepatologyTransplant SurgeryVascular SurgeryGraft SurvivalHepatic PerfusionLiver Blood FlowLiver TransplantationTransplant OutcomesTransplant Rejection90-Day MortalityCohort ConstructionFlow DynamicsGraft Dysfunction EvaluationHepatic Dysfunction AssessmentLiver Volume AssessmentPortal Venous PressureTransplant Outcome Prediction
Background. Portal hyperperfusion is frequently associated with early allograft dysfunction (EAD). It is imperative to identify patients who would require portal inflow modulation. We aimed to identify factors associated with hyperperfusion-related graft injury and develop a predictive index for the same. Methods. Prospectively maintained database was queried to identify 135 adult living donor liver transplant recipients between September 2016 and July 2020. According to the calculated sample size, 96 patients were randomly selected for “ test cohort ”. The remaining 39 patients made the “ validation cohort .” EAD was defined according to the A2ALL study. “Hyperperfusion index (HP i ),” defined as posttransplant portal pressure gradient (Δ P post )/graft-to-recipient splenic volume ratio (GRSVR), was devised on the basis of laws of flow dynamics and regression analysis. Results. Overall, 40 patients (29.6%) had EAD, six 90-d mortalities (4.4%) were attributable to EAD. In the test cohort , EAD patients (n = 29, 30.2%) had lower GRSVR (1.00 versus 2.22, P < 0.001), higher Δ P post (14.8 versus 11.9, P = 0.004), and HP i (20.89 versus 8.67, P < 0.001). Multivariate analysis revealed GRSVR, Δ P post , and HP i as significant factors to predict EAD. Receiver operating characteristic determined cutoff of HP i ≥9.97 could predict EAD with sensitivity of 90% and specificity of 73% (F-score = 0.712). HP i ≥16.25 predicted 90-d mortality with sensitivity of 100% and specificity of 78.9%. Patients with higher HP i had delayed graft-related recovery. Non-EAD patients had a higher 1-y (96% versus 79%) and 2-y (88% versus 79%) survival. The cutoff of HP i was validated well in the validation cohort (F-score = 0.645) (Hosmer-Lemeshow test, P = 0.89). Conclusions. While predicted GRSVR may help identify at-risk patients preoperatively, intraoperatively calculated HP i is more accurate in identifying patients who would require portal inflow modulation. Achieving an HP i below target cutoff significantly decreases the risk of EAD even in low-GRSVR patients.
31
IMPACT OF GRAFT SIZE MISMATCHING ON GRAFT PROGNOSIS IN LIVER TRANSPLANTATION FROM LIVING DONORS1,2
Tetsuya Kiuchi, Mureo Kasahara, Kenji Uryuhara et al. · Transplantation · 1999 · 966 citations
Medicine, Pediatrics, Surgery +16
MINIMUM GRAFT SIZE FOR SUCCESSFUL LIVING DONOR LIVER TRANSPLANTATION
Chung‐Mau Lo, Chi-Leung Liu, John Chan et al. · Transplantation · 1999 · 287 citations
Medicine, Pediatrics, Surgery +16